$ANTX
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Healthcare
Sector
Biotechnology
Industry
Eric E. Easom
CEO
22
Employees
$3.91
Current Price
$29.05M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $346.62 | 327 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $346.62 | 327 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 9 | $50,031.38 | 49,701 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Williams Sarah Joanne Principal Accounting Officer | Sale | 327 | $1.06 | $346.62 | View Details |
| Jan 5, 2026 | Day Lucy Chief Financial Officer | Sale | 3,295 | $1.00 | $3,304.88 | View Details |
| Jan 6, 2026 | Day Lucy Chief Financial Officer | Sale | 5,512 | $1.01 | $5,578.14 | View Details |
| Jan 6, 2026 | Prior Stephen David Chief Strategy Officer | Sale | 2,858 | $1.01 | $2,892.30 | View Details |
| Jan 5, 2026 | Prior Stephen David Chief Strategy Officer | Sale | 3,604 | $1.00 | $3,614.81 | View Details |
| Jan 6, 2026 | Chanda Sanjay Chief Development Officer | Sale | 5,956 | $1.01 | $6,027.47 | View Details |
| Jan 5, 2026 | Chanda Sanjay Chief Development Officer | Sale | 3,295 | $1.00 | $3,304.88 | View Details |
| Jan 5, 2026 | Eizen Joshua M Chief Operating Officer and Chief Legal Officer | Sale | 17,923 | $1.00 | $17,948.09 | View Details |
| Jan 6, 2026 | Eizen Joshua M Chief Operating Officer and Chief Legal Officer | Sale | 6,931 | $1.01 | $7,014.17 | View Details |
9 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.24
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.24
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated-$0.24
Actual-$0.29
Miss
Revenue
EstimatedN/A
ActualN/A
4 more earnings records available โ create a free account to see 12 months of history